Arterys
The profile is currenly unclaimed by the seller. All information is provided by CB Insights.
Executives
7Board of Directors
1Arterys Board of Director
1 Board of directors
Arterys has 1 board of directors, including Khush F Mehta.
Name | Firm | Work History | Other Seats |
---|---|---|---|
Khush F Mehta | Arterys |
Name | Khush F Mehta |
---|---|
Firm | |
Work History | |
Other Seats | Arterys |
Arterys Management Team
7 Team Members
Arterys has 7 executives. Arterys's founder is Shreyas Vasanawala. Arterys's current Founder, Chief Executive Officer is John Axerio Cilies.
Name | Work History | Title | Status |
---|---|---|---|
John Axerio Cilies | Founder, Chief Executive Officer | Current | |
Shreyas Vasanawala | Founder | Current | |
Timothy G Henn | Chief Financial Officer | Current | |
Daniel Arnoff | Senior Vice President | Current | |
Brian Jung | Chief Financial Officer | Former |
Name | John Axerio Cilies | Shreyas Vasanawala | Timothy G Henn | Daniel Arnoff | Brian Jung |
---|---|---|---|---|---|
Work History | |||||
Title | Founder, Chief Executive Officer | Founder | Chief Financial Officer | Senior Vice President | Chief Financial Officer |
Status | Current | Current | Current | Current | Former |
You May Also Like
Aidoc finds and flags critical findings in medical images. By automatically prioritizing urgent, life-threatening conditions like intracranial hemorrhage and pulmonary embolism, Aidoc saves lives, improves patient care and cuts waiting time for the must urgent patients down to only a few minutes. The always-on AI integrates into a radiologist's workflow, reprioritizing cases without forcing radiologists to change the way they work. Aidoc was founded in 2016 and is based in Tel Aviv, Israel.

Ultromics is a global health technology company that provides autonomous echocardiography analysis through AI solutions – empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease. Its cloud-based service, EchoGo, uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

Quibim, a company with its headquarters in Valencia, Spain, provides a whole-body medical imaging analysis. Quibim products are used worldwide by a huge diversity of research and care teams. Partners use Quibim Precision, a CE-marked whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy of treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers.

Enlitic develops a diagnosis system that uses deep learning to analyze medical data in order to enable quick and more accurate detection of diseases that can be identified through medical images such as X-rays and CT scans.

Infervision is a global high-tech enterprise in medical artificial intelligence, aiming to empower doctors with higher efficiency and benefit patients with better diagnosis, outcome, and lower cost. Infervision provides products and services to providers, and patients; with robust A.I. solutions fully integrated with the healthcare workflow to help diagnosing various diseases and conditions such as cerebral hemorrhage, lung cancer, bone fractures, emphysema, and more. Infervision also provides an AI-powered research platform for medical professionals with any research directions and needs.

Perspectum is a provider of digital technologies that help clinicians provide better care for patients with liver disease. The company's work focuses on the detection and accurate, quantitative measurement of liver, gall bladder, and pacreatic disease.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.